CDY 1.43% 7.1¢ cellmid limited

Especially with an Orphan Drug Designation which apparently...

  1. 1,750 Posts.
    lightbulb Created with Sketch. 132
    Especially with an Orphan Drug Designation which apparently speeds things up quite a bit.
    Approval within 90 days is their brief.
    The following link may provide some useful information regarding this and how it may affect the SP which seems to be the main bone of contention around here.
    https://ojrd.biomedcentral.com/articles/10.1186/s13023-017-0665-6

 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.